Early Detection of Pancreatic Cancer in High-Risk Individuals: Where Do We Go From Here?
Where this comes from
- Record sourced from PubMed, PMID 30908300.
- Also identified by DOI 10.14309/ajg.0000000000000192 and PMC identifier 6450722.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pancreatic cancer is a lethal disease that is commonly diagnosed at a late stage. Screening asymptomatic patients is necessary for early detection, but this is not currently recommended in the general population. As demonstrated in the current study, an important number of patients at increased risk can be diagnosed using either MRI/magnetic resonance cholangiopancreatography or endoscopic ultrasound. Further collaborative efforts are needed to define the ideal population for testing and refine the current approach to pancreatic cancer surveillance.
Medical subject headings
- Early Detection of Cancer
- Pancreatic Neoplasms